Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025

About this update from Cannara Biotech, Inc.

[{"type":"text","content":"Cannara Biotech Inc. to Announce Fiscal Q3 2025 Financial Results on July 28, 2025\n\n\n\n MONTREAL, July 21, 2025 (GLOBE NEWSWIRE) --\n \n\n Cannara Biotech Inc.\n \n\n (“\n \n Cannara\n \n ”, “the\n \n Company\n \n ”, “\n \n us\n \n ” or “\n \n we\n \n ”) (\n \n\n TSXV: LOVE\n \n\n ) (\n \n\n OTCQB: LOVFF\n \n\n ) (\n \n\n FRA: 8CB0\n \n\n ), a vertically integrated producer of premium-grade cannabis products at disruptive prices with two mega facilities based in Québec spanning over 1,650,000 sq. ft., today announced that it will release its financial results for the\n \n fiscal third quarter ended May 31, 2025\n \n , on\n \n Monday, July 28, 2025, at 7:00 a.m. ET.\n \n\n\n Cannara Biotech’s CFO, Nicholas Sosiak, will host an earnings webcast on\n \n Monday, July 28, 2025 at 11 a.m. ET\n \n ., consisting of prepared remarks followed by a live question-and-answer session.\n \n\n Participants can register for the conference call and webcast\n \n here\n \n or on the Cannara Biotech website at\n \n https://www.cannara.ca/investors/company-events/\n \n . For interested individuals unable to join, the event will be archived on the company’s website.\n \n\n Investors are encouraged to submit questions in advance to\n \n\n [email protected]\n \n\n . While live questions will be accepted during the session, priority will be given to those submitted by email.\n \n\n\n\n CONTACT\n \n\n\n\n\n Nicholas Sosiak, CPA, CA\n \n Chief Financial Officer\n \n\n [email protected]\n \n\n\n Zohar Krivorot\n \n President & Chief Executive Officer\n \n\n [email protected]\n \n\n\n\n\n\n\n\n Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.\n \n\n\n\n\n ABOUT CANNARA\n \n\n\n\n\n Cannara Biotech Inc.\n \n\n (\n \n\n TSXV: LOVE\n \n\n ) (\n \n\n OTCQB: LOVFF\n \n\n ) (\n \n\n FRA: 8CB0\n \n\n ), is a vertically integrated producer of premium-grade cannabis products at disruptive prices for the Canadian market. Cannara owns two mega facilities based in Québec spanning over 1,650,000 sq. ft., providing the Company with 100,000 kg of potential annualized cultivation output. Leveraging Québ...

More updates from Cannara Biotech, Inc.